CBAT
CBAK Energy Technology, Inc.
There isn't enough reported data to score CBAT yet.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
CBAT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Strong | |
| Weak |
CBAT's revenue and cash flow are currently strong, but its profitability and balance sheet are weak.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CBAT PE Valuation
CBAT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 4.8x next year's earnings.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
CBAT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CBAT to return to profit, with revenue growing.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CBAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.20 | — |
| Q1 2026 | -$0.18 | -$0.18 |
| Q4 2025 | -$0.10 | -177% |
| Q3 2025 | -$0.07 | -154% |
| Q2 2025 | -$0.10 | -150% |
| Q1 2025 | $0.00 | -100% |
| Q4 2024 | $0.13 | +$0.16 |
| Q3 2024 | $0.13 | +$0.23 |
| Q2 2024 | $0.20 | +$0.37 |
CBAT is still losing money, but less than at its worst: $0.18 per share over the past year, against $0.35 at its worst in late 2019.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
CBAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $69.6M | +99% |
| Q4 2025 | $58.8M | +132% |
| Q3 2025 | $60.9M | +37% |
| Q2 2025 | $40.5M | -15% |
| Q1 2025 | $34.9M | -41% |
| Q4 2024 | $25.4M | -55% |
| Q3 2024 | $44.6M | -30% |
| Q2 2024 | $47.8M | +13% |
EOSE has the stronger quarterly revenue trend. Revenue is up 99% for CBAT versus up 171% for EOSE.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -14% | -5.7 points |
| Q4 2025 | -14% | +12 points |
| Q3 2025 | -6.6% | -4.8 points |
| Q2 2025 | -8.7% | -21 points |
| Q1 2025 | -8.2% | -26 points |
| Q4 2024 | -26% | -16 points |
| Q3 2024 | -1.9% | -10 points |
| Q2 2024 | 12% | +21 points |
CBAT's operating margin was −14% last quarter, down 5.7 points from the same quarter a year ago.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE's revenue has grown year over year for 10 quarters in a row: $83M last quarter, up 171% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
CBAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $10.5M | +$32.8M |
| Q4 2025 | $16.1M | +310% |
| Q3 2025 | $6M | -64% |
| Q2 2025 | $4.1M | +65% |
| Q1 2025 | -$22.3M | -$21.9M |
| Q4 2024 | $3.9M | -80% |
| Q3 2024 | $16.5M | +$17M |
| Q1 2024 | -$454K | -105% |
CBAT has the stronger cash trend. Its trailing FCF is up 6,165% versus its history, compared with EOSE at down 140%.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
CBAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -0.8% | -692K shares |
| 3 years | +0.3% | +234K shares |
| 5 years | +5.1% | +4.3M shares |
| Available history | +152% | +53.9M shares |
CBAT has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $263,111 |
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CBAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 8.4x | High |
| Q4 2024 | 3.6x | Elevated |
| Q3 2024 | 2.9x | Moderate |
| Q2 2024 | -0.3x | Net Cash |
| Q1 2024 | 1.2x | Healthy |
| Q4 2023 | -1.8x | Net Cash |
CBAT's net debt is about 8.4 years of its operating earnings (EBITDA), up from 1.2 years a year ago.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CBAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 48.3 | Neutral |
CBAT's weekly RSI is 52 (neutral) and its Stochastic is 48 (neutral).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CBAT PE vs Industrials Sector
| Metric | CBAT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
CBAT has no meaningful PE right now: it lost money over the past year.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
CBAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.08 | 11% below |
| 20 week MA | $0.88 | 9.1% above |
| 50 week MA | $0.85 | 13% above |
| 100 week MA | $0.89 | 7.9% above |
| 200 week MA | $0.97 | 1% below |
CBAT has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
CBAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.14 | $6.26 | +449% |
| 2021 | $6.26 | $1.69 | -73% |
| 2022 | $1.69 | $0.98 | -42% |
| 2023 | $0.98 | $1.05 | +7.1% |
| 2024 | $1.05 | $1.07 | +1.9% |
| 2025 | $1.07 | $0.86 | -20% |
| 2026 YTD | $0.86 | $0.96 | +12% |
CBAT has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.